Chugai Pharma USA, Inc.

United States of America (USA)

1 December 2019 - 30 November 2020

No articles found. Chugai Pharma USA, Inc. did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

F. Hoffmann-La Roche AG

↳ Chugai Pharmaceutical Co., Ltd.

↳ Chugai Pharma USA, Inc.

Chugai Pharmabody Research Pte. Ltd.

Roche S.A.S

454 Life Sciences

Anadys Pharmaceuticals, Inc.

Ariosa Diagnostics, Inc.

Bina Technologies, Inc.

F. Hoffmann-La Roche Ltd.

Roche Innovation Center Copenhagen A/S

Roche Translational and Clinical Research Center (TCRC)

Flatiron Health, Inc.

Genentech, Inc.

Department of Early Stage Pharmaceutical Development, Genentech, Inc.

Genia Corporation

Hoffmann-La Roche, Inc.

InterMune, Inc.

Piramed Ltd.

Roche Deutschland Holding GmbH

Roche Diabetes Care IT

Roche Diagnostics Asia Pacific Pte Ltd.

Roche Diagnostics Corporation

Roche Diagnostics S.L.

Roche Farma, S.A.

Roche Molecular Systems, Inc.

Roche Nederland B.V.

Roche NimbleGen, Inc.

Roche Nutley

Roche Palo Alto, LLC

Roche Pharmaceuticals - Poland

Roche Products Limited

Roche R&D Center (China) Ltd.

Roche Sequencing Solutions (RSS)

Ventana Medical Systems, Inc.

Return to institution outputs

Latest supplement

Nature Index 2021 Asia Pacific

Sustainability, climate-change mitigation, and biomedical science are key areas for future research prowess in the Asia-Pacific region. While COVID-19 travel restrictions have disrupted collaborations between far-flung nations, they have focused attention on vast opportunities for researchers in countries in close proximity and South and southeast Asia to work more closely together on new initiatives.

Access free